MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders

    N. Shah, N. Chunga, K. Amodeo, I. Richard (Rochester, USA)

    Objective: To describe factors associated with triggering a best practice advisory (BPA) for dopamine-blocking agents (DBA) and report preliminary outcomes in hospitalized persons with Parkinson’s…
  • 2024 International Congress

    Walking reduced the risk of Parkinson’s disease dementia: a retrospective longitudinal follow-up study

    CY. Wei, PY. Chiu (Changhua County, Taiwan)

    Objective: We aimed to test whether the minimal amount of exercise (MAE) of walking, which is practical for people with motor dysfunction, could help prevent…
  • 2024 International Congress

    Cognitive Impairment in a Cohort of Patients with DBS for parkinson’s disease treatment from a multicentric Cohort in Colombia

    T. Lopez Gonzalez, S. Poveda, M. Fonseca, P. Arango, O. Rojas, G. Monsalve, J. Diez, J. Lobato, O. Bernal Pacheco (Bogota, Colombia)

    Objective: The objective of the present work is to investigate the clinical outcomes related to cognitive performance in Colombian patients with DBS treatment. Background: Parkinson's…
  • 2024 International Congress

    Subtyping Parkinson’s Disease Mild Cognitive Impairment (PD-MCI) by Cholinergic Degeneration

    A. Negida, H. Vohra, H. Nawaz, M. Barrett (Henrico, USA)

    Objective: This study aims to investigate whether PD-MCI patients exhibiting cholinergic degeneration, evidenced by reduced Ch4 grey matter density (GMD) on brain MRIs, constitute a…
  • 2024 International Congress

    Behavior medicine perspectives in pre-DBS patients with ET and PD

    D. Kim, S. O'Neill, S. Murthy, A. Waters, C. Palmese (Bronx, USA)

    Objective: The goal of this study is to identify behavior medicine variables in patients with ET and PD that can guide DBS surgical planning and…
  • 2024 International Congress

    TRPV1: A Potential Therapeutic Target for Inflammation and Pain in Parkinson’s Disease

    SJ. Song, YE. Kim (Anyang, Republic of Korea)

    Objective: Unveiling the Pain Mechanism in Parkinson's Disease: A Path to New Therapies Background: Parkinson's disease (PD) are well-known movement disorder. While motor symptoms are…
  • 2024 International Congress

    Prevalence of Non-Motor Symptoms in Patients with Parkinson Disease in a Tertiary Hospital in Santiago, Chile.

    M. Sánchez, V. Rosado, C. Montalva, P. Salles, J. Fuentes, P. Chaná (Santiago, Chile)

    Objective: Objective:Determine the prevalence of NMS in patients with Parkinson disease attending the Hospital San Juan de Dios Neurology Clinic. Background: Background:Parkinson disease (PD) is…
  • 2024 International Congress

    Interim Report of Quality of Life Outcomes After Deep Brain Stimulation for Parkinson’s Disease from a Large Global Real-World Study

    A. Gharabaghi, L. Lopez, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Tuebingen, Germany)

    Objective: To summarize quality of life outcomes after 2 years of deep brain stimulation (DBS) for Parkinson’s disease (PD). Background: DBS improves motor fluctuations associated…
  • 2024 International Congress

    The Contribution of Cognitive and Affective Factors to Balance Control in People with Parkinson’s Disease Attending an Outpatient Clinic

    E. Spasova, C. O'Keeffe, A. Blanco-Campal, J. Inocentes, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: The central aim of this cross-sectional study is to define the cognitive and affective contributors to balance control assessment in a cohort of people…
  • 2024 International Congress

    Listening to the Insight: The Underdiagnosis of Depression in People Living with Parkinson’s Disease

    G. Rivera-Monroy, RJ. Baños-Betancourt, K. Velázquez-Román, CF. álvarez-Hernández, AL. Guerra-Anzaldo, WF. Moguel-Cardín, A. Domínguez-García, MF. Medina-Pérez, JC. Delgado-Uriarte, NP. Moreno-Aldama, A. Uribe-León, MC. Unda-Mcfarlane, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To determine the prevalence of risk of undiagnosed depression among people living with Parkinson's disease (PwP) without a prior depression diagnosis. Background: Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley